Entero Therapeutics, Inc. (ENTO)
NASDAQ: ENTO · Real-Time Price · USD
0.493
-0.032 (-6.04%)
Feb 21, 2025, 4:00 PM EST - Market closed
Entero Therapeutics Market Cap
Entero Therapeutics has a market cap or net worth of $2.35 million as of February 21, 2025. Its market cap has decreased by -31.02% in one year.
Market Cap
2.35M
Enterprise Value
2.14M
1-Year Change
-31.02%
Ranking
Category
Stock Price
0.49
Market Cap Chart
Since October 11, 2016, Entero Therapeutics's market cap has decreased from $49.20M to $2.35M, a decrease of -95.23%. That is a compound annual growth rate of -30.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 2.30M | -23.33% |
| Dec 31, 2024 | 3.00M | 7.14% |
| Dec 29, 2023 | 2.80M | -45.10% |
| Dec 30, 2022 | 5.10M | -71.67% |
| Dec 31, 2021 | 18.00M | -38.98% |
| Dec 31, 2020 | 29.50M | 8.46% |
| Dec 31, 2019 | 27.20M | 32.68% |
| Dec 31, 2018 | 20.50M | -51.19% |
| Dec 29, 2017 | 42.00M | -7.89% |
| Dec 30, 2016 | 45.60M | -7.32% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |